Functional Characterization of Two Thioredoxin Proteins of Toxoplasma gondii Using the CRISPR-Cas9 System

Introduction

Toxoplasma gondii is an obligate parasite that belongs to the apicomplexa with a worldwide distribution (1). This parasite can infect almost all warm-blooded animals and ~1/3rd of the world population are seropositive (2). Horizontal transmission of T. gondii occurs via consumption of raw or undercooked meat containing tissue cysts or by ingestion of water, food, and soil contaminated with oocysts (1, 3). In immunologically healthy subjects, most people are asymptomatic (2). However, in immunocompromised individuals, especially in patients with AIDS and organ transplants, the symptoms that toxoplasmosis causes are severe, or even life-threatening (4). Toxoplasmic encephalitis is the primary manifestation in these patients, accompanied by headache, ataxia, loss of memory, fever, and other symptoms (1, 5). In addition, T. gondii can be transmitted via vertical transmission (6). It is noticeable that the placenta is not only a barrier to protect fetus but also a target organ where T. gondii multiplication occurs. Once transplacental transmission occurs in the first and second trimesters, it leads to severe influence on the growth of fetus, probably resulting in microcephalus, hydrocephalus, cataract, strabismus, retinochoroiditis even abortion (1, 2, 7).

As an aerobiont, T. gondii can multiply rapidly within host cells at the infective stage of tachyzoites. To survive, T. gondii must undergo the redox stress which is induced by the microenvironment of host cells. This parasite not only eliminates oxidized material activity, but also resists the damage of reactive oxygen species (ROS) generated by host cells (8, 9). Thus, there should be a variety of mechanisms to balance the redox state in T. gondii, which is hypersensitive to redox imbalance.

Several peroxidases of T. gondii, including catalase, peroxiredoxin, superoxide dismutase (SOD), glutathione peroxidase, and thioredoxin (Trx) peroxidase, constitute the antioxidant network to protect this parasite from damage of ROS (9). T. gondii uses catalase to eliminate the by-products of peroxisome, such as H₂O₂. Peroxiredoxin can assist catalase to detoxify ROS, and it also protects T. gondii against H₂O₂ stress (10). There are two classical antioxidant systems in this parasite, namely glutaredoxin (Grx) system and thioredoxin (Trx) system, which serve as thiol-disulfide pairs to control the redox balance of T. gondii (9, 11). Glutaredoxin, glutathione (GSH), nictinamide adenine dinucleotide phosphate (NADPH), and glutathione reductase constitute one of the classical antioxidant systems, namely Grx system (9, 12). After reacting with target protein that contains disulfide bond, Grx becomes oxidized form, and then is reduced by GSH. NADPH and glutathione reductase operate together to reduce GSSG that means oxidized GSH, to become reduced form (13). Some Grx, such as human Grx2, can utilize electrons supplying from TrxR to keep redox balance (14). The basic biological functions of Grx are to maintain the ratio of GSH/GSSG at the normal level and the high concentration of thiol groups within cells, which overlaps the function of Trx to some extent (15). Thioredoxin system consists of thioredoxin (Trx), thioredoxin reductase (TrxR) and NADPH, which is ubiquitous in eukaryotes and prokaryotes (16). Oxidized thioredoxin, Trx-S₂, forms after thiol-disulfide exchange reactions occurred via Trx-(SH)₂ and oxidized proteins, and Trx-S₂ is reduced by TrxR and NADPH that serves sufficient hydrogen electrons. Three components of this system participate mutually in several biological activities to protect organisms from oxidized damage and apoptosis (16, 17). The physiological function of Trx in virtually all organisms is to keep cytoplasmic proteins with reduced form, which means relatively stable (18).

The physiological functions of Trxs may be multiple in different organisms, evolving from catalyzing thiol-disulfide exchange reaction to specialized functions. It seems that Trx is “moonlighting protein,” and the functions of Trxs in T. gondii are still unclear. Here, we used the CRISPR-Cas9 technique to study two Trx genes, namely CTrp26 (TGME49_290260) and CTrx1 (TGME49_266620), in the virulent T. gondii RH strain. The subcellular localization of the two Trxs, the abilities of Trx-deficient tachyzoites to form plaque, replicate, egress, resist H₂O₂ and maintain ROS level and total antioxidant capacity (T-AOC) in vitro and the virulence in mice in vivo were evaluated.

Materials and Methods

Parasite and Cell Cultures

The tachyzoites of T. gondii RH strain (Type I, ToxoDB#10) were maintained in vitro in human foreskin fibroblast (HFF, ATCC®, SCRC-1041^TM) at 37°C,5% CO₂ atmosphere. HFF cells were cultured in Dulbecco's Modified Eagle medium (DMEM) supplemented with 2% fetal bovine serum (FBS), 10 mM HEPES (pH 7.2), 100 Ug/ml streptomycin, and 100 U/ml penicillin (19). Infected cells were cracked by 27-gauga needle to release tachyzoites and then filtered using Millipore filter of 5 μm pore size.

Construction of Trx Mutant Strains

Trx knockout strains were generated using CRISPR-Cas9 approach as previously described (19). All primers used in this study are listed in Supplementary Table 1. Briefly, SgRNA of each Trx was inserted into the plasmid pSAG1-Cas9-SgUPRT to replace the UPRT targeting RNA using a Q5 Mutagenesis Kit (NEB). After sequencing, positive plasmids were extracted by using an Endo-Free Plasmid DNA Mini Kit (Omega). The 5′ and 3′ homologous arms of each Trx were amplified from the genomic DNA of T. gondii RH strain with each pair of specific primers listed in Supplementary Table 1. The plasmid pUPRT-DHFR-D was used as the template to generate DHFR fragment. Then three fragments mentioned above were engineered into the plasmid pUC19 with multi-fragment cloning method using a CloneExpress II one-step Cloning Kit (Vazyme). Positive plasmids were used to amplify the fragment of 5HR-DHFR-3HR to generate the homologous templates. About 40 μg positive plasmids of CRISPR-Cas9 and 15 μg purified fragment of 5HR-DHFR-3HR templates were co-transfected into tachyzoites of T. gondii RH strain by electroporation. Single strain clones were obtained by limiting dilution method and cultured in 96-well-plates with 3 μM pyrimethamine. Trx knockout strains were confirmed by PCR and RT-PCR as previously described (20).

C-Terminal Tagging

The CRISPR-Cas9 plasmids of each Trx that targets the 3′ region of each gene were constructed as previously described (21). The PCR product of each Trx that contains ~1.5 kb of 3′ region of a Trx gene (except the STOP codon) and the fragment of 10×HA and DHFR was amplified from the p10×HA-LIC-DHFR plasmids as the template using a pair of specific primers. The purified fragment and C-terminal Trx-specific CRISPR-Cas9 plasmids were mixed and co-transfected into freshly egressed tachyzoites of T. gondii RH strain using electroporation. Single positive clones were identified by PCR and immunofluorescence analysis (IFA).

Western Blotting and Immunofluorescence Analyses

For Western blotting, freshly purified tachyzoites of T. gondii RH strain were lysed by RIPA lysis buffer on ice to obtain proteins and were used for SDS-PAGE analysis, then transferred to polyvinylidene fluoride (PVDF) member. The primary antibodies used in Western blotting were rabbit anti-Aldolase (1:500) and rabbit anti-HA (1:1,000) (21).

For immunofluorescence analysis (IFA), HFF cells were infected with freshly egressed tachyzoites of T. gondii RH strain and were fixed with 4% paraformaldehyde, then penetrated with 0.2% Triton X-100 for 20 min. After blocked by 5% BSA diluted in PBS for 1 h, infected cells were incubated with rabbit anti-IMC1 (1:1,000) and mouse anti-HA (1:500) as primary antibodies at 4°C for overnight, and then incubated with Alexa Fluor 488 anti-rabbit IgG (1:1,000) and Alexa Fluor 594 goat anti-mouse IgG (1:1,000) as secondary antibodies at 37°C for 1 h. The samples were imaged using a Leica confocal microscope system (tcs sp52, Leica, Germany) (21).

Plaque Assay

About 200 tachyzoites of Trx knockout and wild-type (WT) RH strains were inoculated into 12-well-plates containing monolayer of HFF cells, and the 12-well-plates were inoculated for 1 week under 37°C, 5% CO₂ environment. The medium was removed and the infected cells were fixed with 4% paraformaldehyde for 30 min and stained with 0.5% crystal violet for 10 min at ambient temperature. The number and size of plaques were counted and analyzed (22).

Intracellular Replication

Tachyzoites of T. gondii RH strain were incubated into cell culture dishes containing monolayer of HFF cells for 1 h, with about 10⁵ tachyzoites of each Trx knockout or WT strains per dish. After removing old medium, the dishes were washed three times to remove extracellular parasites. Then, infected cells were added with new culture medium and maintained at 37°C with 5% CO₂ atmosphere for 23 h. HFF cells were fixed with 4% paraformaldehyde for 30 min and stained with mouse anti-SAG1, followed by Alexa Fluor 594 goat-anti mouse IgG. Parasitophorous vacuoles (PVs) were selected randomly for analysis, and the numbers of parasites contained in PVs were recorded (22).

Egress Assay

Cell culture dishes containing monolayer of HFF cells were inoculated with freshly harvested tachyzoites of Trx knockout or WT strains, with about 10⁵ tachyzoites per dish, and were maintained at 37°C with 5% CO₂ for 1 h. Then the dishes were washed three times with PBS to remove floating parasites and added with fresh culture medium to continue to culture for further 30–36 h. Then infected cells were treated with 3 μM calcium ionophore A23187 diluted in DMEM. The timing and images of parasites to egress from host cells were recorded by live cell microscopy (20).

H₂O₂ Resistance Analysis

Freshly egressed tachyzoites were cultured in regular DMEM or DMEM containing 1.6 mM H₂O₂ for 1 h at 37°C, 5% CO₂ atmosphere, then centrifuged at 1,000 g to remove the supernatants. Parasites were re-suspended in DMEM and inoculated into 12-well-plates containing monolayer of HFF cells to culture for 40 h. After being fixed with 4% paraformaldehyde, the samples were stained with mouse anti-SAG1, followed by Alexa Fluor 594 goat-anti mouse IgG. PVs were selected to count the number of parasites that PVs contained.

Detection of ROS Level in Trx Mutant Strains

Infected cells were cracked by 27-gauga needle to release tachyzoites. 1 × 10⁶ purified tachyzoites were labeled with DCFH-DA (Beyotime, China) and suspended in DMEM. After incubated darkly at 37°C, 5% CO₂ atmosphere for 1 h, samples were centrifuged at 1,200 g to remove the supernatants and washed three times with PBS. Total fluorescence intensity of tachyzoites were determined with fluorescence microplate reader (Spectra Max M5, MD, USA) with 488 nm of excitation wavelength and 525 nm of emission wavelength.

Analysis of Total Antioxidant Capacity

Purified tachyzoites were resuspended in PBS and broken with ultrasonic cell disruptor (Uibra-Cell, Sonics, USA). The suspensions were centrifuged at 12,000 g under 4°C to extract proteins of T. gondii. T-AOC was measured by T-AOC assay kit (Beyotime, China) according to the manufacturer's instructions. The results were represented as total antioxidant capacity in per gram of protein.

Mouse Infection With Trx- Deficient Strains

Specific-pathogen-free (SPF) Kunming mice (female, 7 weeks old) were purchased from The Center of Laboratory Animals, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences. Mice (5 mice/cage) were habituated for 1 week to reduce stress response before experiment. Mice were infected with freshly egressed tachyzoites of Trx knockout or WT strains (10 mice/strain) by intraperitoneal injection, with 100 tachyzoites of T. gondii RH strain per mouse. All mice were recorded daily for the progression of illness and death time.

Statistical Analysis

The differences of experiments in vitro and in vivo were analyzed using Student's t-test and Gehan–Breslow–Wilcoxon test with GraphPad Prism 5 (GraphPad Software, La Jolla, CA, USA). Data obtained from three independent experiments were presented as means ± standard deviations (SD). The differences were considered statistically different when P-value was below 0.05.

Results

Localization of CTrp26 and CTrx1

To determine the subcellular localization of CTrp26 and CTrx1 in T. gondii, 10×HA (~39 kDa) was inserted into the C-terminus of CTrp26 or CTrx1 gene endogenous locus. IFA results showed that CTrp26 and CTrx1 were both located in the cytoplasm of T. gondii (Figure 1A). The findings were consistent with the results of Western blotting analysis, with the bond of CTrp26 and CTrx1 occurred between 55 and 70 kDa (Figure 1B).

FIGURE 1

Figure 1. Immunofluorescence analysis and Western blotting of CTrp26 and CTrx1. (A) Immunofluorescence analysis shows that both CTrp26 and CTrx1 are located in cytoplasm of Toxoplasma gondii. (B) Western blotting confirmed that the 10×HA were successfully inserted into the C terminal of CTrp26 or CTrx1. The 10×HA tagged CTrp26 and CTrx1 are about 62.3 and 61.7 kDa, respectively. Anti-adolase (ALD) was served as a loading control.

Construction of RHΔCTrp26 and RHΔCTrx1 Strains by CRISPR-Cas9

CRISPR-Cas9 technique was used to delete the CTrp26 and CTrx1 genes in type I RH strain, and CTrp26 or CTrx1 coding region was replaced by 5HR-DHFR-3HR fragment with homologous recombination technology (Figure 2A). Single clones obtained from drug selection and limiting dilution methods were confirmed by PCR, and ~600 bp fragment was amplified in the WT strain but was not detected in KO strains because of the replacement by the 5HR-DHFR-3HR fragment (Figure 2B). RT-PCR method was also used to confirm the deletion of CTrp26 or CTrx1 gene at the mRNA level, with ~200 bp fragment detected in the WT strains and no fragment found in KO strains (Figure 2C). Our results showed that CTrp26 and CTrx1 genes were disrupted by CRISPR-Cas9-mediated homologous recombination technology and that RHΔCTrp26 and RHΔCTrx1 strains were successfully constructed.

FIGURE 2

Figure 2. Construction of CTrp26 or CTrx1 knockout strains. (A) Schematic representation of deleting CTrp26 or CTrx1 by CRISPR-Cas9-mediated homologous replacement. (B) Diagnostic PCRs show that CTrp26 or CTrx1 gene was successfully disrupted, which is confirmed by at mRNA level (C).

Disruption of CTrp26 or CTrx1 Gene Did Not Affect the Growth and Egress of T. gondii

Plaque assay was used to compare the ability of plaque formation between RHΔCTrp26 or RHΔCTrx1 knockout strains and WT strains (Figure 3). HFF cells grown in 12-well-plate were infected with about 200 tachyzoites of Trx mutants or WT strains to allow parasites to grow for 7 days, and the size and number of plaques were analyzed. Results showed that there were no significant differences in the size and number of plaques between cells infected with RHΔCTrp26 or RHΔCTrx1 knockout tachyzoites and WT strains.

FIGURE 3

Figure 3. The lytic cycle of RHΔCTrp26 or RHΔCTrx1 knockout strains and WT strain in vitro. (A) Plaque assay of Trx mutant strains and WT strain. (B) Relative size of the plaques generated by Trx mutant strains and WT strain showed no significant differences between WT strain and any of Trx mutant strains. n. s, not significant.

Subsequently, we investigated the role of Trxs on egress process of T. gondii, 3 μM calcium ionophore A23187 were used to treat HFF cells infected with RHΔCTrp26 or RHΔCTrx1 knockout tachyzoites and WT strains, and the egress process was recorded by time-lapse microscopy over 5 min (Figure 4A). The results showed that most Trx mutants and WT strains egressed from host cells within 2 min, with no significant differences in egress process being observed among different strains.

FIGURE 4

Figure 4. Egress process and intracellular replication of CTrp26 or CTrx1 knockout strains and WT strain in vitro. (A) Representative image shows that one of Trx mutant strains (ΔCTrx1) and WT strain egress within 2 min after addition of 3 μM calcium ionophore A23187. (B) WT strain and Trx mutant strains have similar intracellular replication dynamic. n. s, not significant.

To evaluate the effect of Trxs on the intracellular replication of T. gondii, Trx mutants, and their parental strains were incubated into cell dishes containing monolayer of HFF cells for 24 h, and were fixed with 4% paraformaldehyde to count tachyzoite numbers that PVs contained (Figure 4B). Results showed that the ability of intracellular growth of RHΔCTrp26 or RHΔCTrx1 knockout strains and their parental strains was similar.

Deletion of CTrp26 or CTrx1 Gene Did Not Affect the Sensitivity of T. gondii to H₂O₂ Exposure

Extracellular parasites treated with regular DMEM or DMEM containing H₂O₂ were inoculated into HFF monolayers to examine whether RHΔCTrp26 and RHΔCTrx1 knockout strains were more sensitive to oxidative stress compared with WT RH strain. The results showed that the proliferation rates of the three strains were similar under the same condition (control group or treatment group) (Figure 5); however, the ability of intracellular growth associated with treatment group was significantly lower than that in control group (P < 0.05), suggesting that oxidative stress inhibited the proliferation of tachyzoites, but RHΔCTrp26 and RHΔCTrx1 strains were not more sensitive to H₂O₂ exposure compared with WT RH strain.

FIGURE 5

Figure 5. Effect of H₂O₂ on T. gondii proliferation associated with RHΔCTrp26 or RHΔCTrx1 knockout strains and WT strain in vitro. Control and treatment represent parasites treated with regular DMEM and DMEM containing H₂O₂, respectively. n. s, not significant.

Analysis of ROS Level and T-AOC in RHΔCTrp26 and RHΔCTrx1 Strains

To investigate ROS level in Trx mutants and WT strains, tachyzoites of the three strains were labeled with DCFH-DA (reduced form) and measured with fluorescence intensity of DCF (oxidized form) that reflects ROS level in T. gondii. The results showed that there were no significant differences in ROS level among RHΔCTrp26, RHΔCTrx1, and WT strains (Figure 6A), suggesting that disruption of CTrp26 or CTrx1 gene had no effect on ROS level in T. gondii RH strain.

FIGURE 6

Figure 6. Responses of oxidative stress on RHΔCTrp26 or RHΔCTrx1 knockout strains in vitro. (A) The reactive oxygen species level in RHΔCTrp26 or RHΔCTrx1 knockout strains and WT strain. (B) The total antioxidant capacity in RHΔCTrp26 or RHΔCTrx1 knockout strains and WT strain. n. s, not significant.

Furthermore, we evaluated whether CTrp26 or CTrx1 deletion can affect the T-AOC of T. gondii. Extracted protein of tachyzoites was used to examine T-AOC using T-AOC assay kit (Beyotime, China). Our results revealed that T-AOC in per gram of protein among three strains were similar (Figure 6B), indicating that CTrp26 or CTrx1 plays no role in T-AOC in RH strain of T. gondii.

Deletion of CTrp26 or CTrx1 Gene Did Not Attenuate the Virulence of T. gondii in Mice

To evaluate whether the deletion of Trxs can attenuate the pathogenicity of the parasite to mice, Kunming mice were intraperitoneally injected with 100 tachyzoites of RHΔCTrp26, RHΔCTrx1, or WT strains, and the morbidity and mortality were recorded daily (Figure 7). The results showed that all mice died within 9–12 days, suggesting that Trxs are not virulence factors and do not alter lethal action of T. gondii RH strain in mice.

FIGURE 7

Figure 7. Survival of Kunming mice infected with Trx mutant strains and WT strain of T. gondii. The mice (10/group) were intraperitoneally injected with 100 tachyzoites of each strain. The death time of mice were recorded until all mice died.

Discussion

Some of the Apicomplexan parasites, such as Plasmodium falciparum and T. gondii, result in severe zoonoses like malaria and toxoplasmosis (8). These parasites are aerobian protozoans that are supersensitive to the microenvironment of the host cells (8). They adapt to environmental conditions they live, thus have developed several antioxidant mechanisms to tackle the oxidative stress generated by the host cells.

There are three classic thioredoxins (PfTrx1–3) and two thioredoxin-like proteins (PfTlp1–2) that have been identified in P. falciparum (23). PfTrx1 is a cytoplasmic protein that can directly reduce oxidized glutathine and deloxify H₂O₂ to counteract oxidative stress (24). Although PfTrx2 was reported originally to locate in mitochondria, recent research revealed that PfTrx2 is the component of the translocon of exported proteins (PTEX) in PVs and involved in the protein trafficking from P. falciparum to host cells (25). PfTrx3 is located in the endoplasmic reticulum (ER) to fold target proteins via formation of disulfide band (24). However, limited studies have focused on the two thioredoxin-like proteins of P. falciparum, and the physiological functions of PfTlp1–2 remain unclear (23).

Catalase (CAT) is lacking in most protozoa, whereas it exists in T. gondii (26). A previous study indicated that CAT plays a role in the proliferation of T. gondii within PVs, because when CAT gene was deleted, parasites appeared more sensitive to H₂O₂ exposure and was less virulent to mice (27). Peroxiredoxin 2 (Prx2) is also an antioxidant enzyme that locates in the cytoplasm of T. gondii, it not only helps CAT to detoxify ROS, but also can eliminate H₂O₂ by itself (28). Prx2-overexpression parasites showed strong resistance to oxidative stress (27). In addition, there are also classical antioxidant systems in T. gondii, especially the thioredoxin (Trx) system, which contains three members, namely thioredoxin (Trx), thioredoxin reductase (TrxR) and nictinamide adenine dinucleotide phosphate (NADPH). The three members of the Trx system operate mutually in order to balance the redox state in T. gondii. However, studies of the Trx system in T. gondii is limited, and the functions of Trx in T. gondii infection remain unclear.

Only a few studies have focused on the biological functions of Trx in T. gondii RH strain. To date, two Trxs have been identified in T. gondii. TgATrx1 is located in the outermost compartment of apicoplast, cytoplasm and ER (29). TgATrx2 is an apicoplast periplastid protein, whose phenotype enrichment score is −2.87 (8, 30). Both TgATrx1 and TgATrx2 are essential for the growth of T. gondii, and conditional depletion of either of two Trxs leads to loss of plaque formation, which indicated that generated parasites displayed severe grow defect in the absence of TgATrx1 or TgATrx2 protein (8), suggesting that TgATrx1 is in control of protein trafficking from ER to apicoplast, and TgATrx2 affects genome copy number of apicoplast (8).

In the present study, we generated a transgenic parasite by inserting a 10×HA tag into C-terminal of CTrp26 or CTrx1 to investigate the subcellular localization of CTrp26 and CTrx1 in T. gondii. IFA showed that both CTrp26 and CTrx1 were located in the cytoplasm of T. gondii tachyzoites. Furthermore, results of Western blotting confirmed that CTrp26 and CTrx1 were expressed successfully with the HA tags.

CRISPR-Cas9 technique was used to disrupt CTrp26 and CTrx1 in type I RH strain of T. gondii, and RHΔCTrp26 strain and RHΔCTrx1 strain were constructed. The number and size of plaques that generated by RHΔCTrp26, RHΔCTrx1 and WT RH strains were not significantly different, suggesting that CTrp26 and CTrx1 did not play role in several lytic cycles of T. gondii RH strain. Furthermore, intracellular replication and egress assay revealed that the replication and egress efficiencies of CTrp26 mutant and CTrx1 mutant were comparable to that of RH WT strain. Moreover, the survival of mice was recorded in order to investigate the functions of CTrp26 and CTrx1 in vivo. All mice died within 9-12 days, indicating that CTrp26 and CTrx1 were not important virulence factors and deletion of either of the two genes did not attenuate the virulence of T. gondii RH strain in mice. The phenotype enrichment scores of CTrp26 and CTrx1 are 0.42 and 1.28, respectively, which indicates that CTrp26 and CTrx1 are not essential genes in RH strain.

Considering that the function of Trx is keeping the redox balance, we also investigated the resistance of T. gondii to H₂O₂ exposure, ROS level and T-AOC of T. gondii. H₂O₂ exposure could inhibit the proliferation of tachyzoites of RHΔCTrp26, RHΔCTrx1 mutants and RH WT strain; however, the sensitivity of the three strains was similar, suggesting that CTrp26 and CTrx1 do not play role in resistance of H₂O₂ damage in T. gondii RH strain. Our results revealed that the disruption of CTrp26 or CTrx1 in T. gondii RH strain did not influence the ROS level in Trx mutant strains. The deletion of CTrp26 or CTrx1 did not reduce T-AOC of T. gondii RH strain.

Conclusion

Using CRISPR-Cas9 technique, the present study examined the basic biological functions of CTrp26 and CTrx1 in T. gondii RH strain in vitro and in vivo. Our results showed that CTrp26 and CTrx1 are both located in the cytoplasm of tachyzoites. Deletion of either of the two Trxs did not affect intracellular replication, egress process, plaque formation, H₂O₂ resistance, ROS level, and T-AOC of this parasite in vitro, and these two Trxs did not serve as virulence factors in T. gondii RH strain in Kunming mice. Further research will focus on the functions of CTrp26 and CTrx1 in other genotypes of T. gondii and the roles these two Trxs play when T. gondii undergo the damage of other ROS.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Materials, further inquiries can be directed to the corresponding author/s.

Ethics Statement

The animal study was reviewed and approved by the Animal Ethics Committee of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences.

Author Contributions

J-LW and X-QZ designed the study. Z-WZ performed the experiments, analyzed the data, and wrote the manuscript. J-LW, Q-LL, and X-QZ revised the manuscript. T-TL, H-SZ, and L-XS participated in implementation of the study. All authors read and approved the final version of the manuscript.

Funding

Project support was kindly provided by the National Natural Science Foundation of China (Grant No. 31802180), the Agricultural Science and Technology Innovation Program (ASTIP) (Grant No. CAAS-ASTIP-2016-LVRI-03), and the Yunnan Expert Workstation (Grant No. 202005AF150041).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank Professor Bang Shen (Huazhong Agricultural University) for providing the pSAG1-Cas9-SgUPRT and pUPRT-DHFR-D vector.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fvets.2020.614759/full#supplementary-material

References

1. Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. (2012) 25:264–96. doi: 10.1128/CMR.05013-11

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. (2004) 363:1965–76. doi: 10.1016/S0140-6736(04)16412-X

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Wang JL, Zhang NZ, Li TT, He JJ, Elsheikha HM, Zhu XQ. Advances in the development of anti-Toxoplasma gondii vaccines: challenges, opportunities, and perspectives. Trends Parasitol. (2019) 35:239–53. doi: 10.1016/j.pt.2019.01.005

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Feleke DG, Gebreweld A, Zewde G. Toxoplasmosis in pregnant women and HIV/AIDS patients in Ethiopia: a systematic review and meta-analysis. J Parasitol Res. (2019) 2019:4670397. doi: 10.1155/2019/4670397

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Elsheikha HM, Marra CM, Zhu XQ. Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis. Clin Microbiol Rev. (2021) 34:e00115–19. doi: 10.1128/CMR.00115-19

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, Bonithon Kopp C, et al. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis. (2013) 56:1223–31. doi: 10.1093/cid/cit032

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Rico-Torres CP, Vargas-Villavicencio JA, Correa D. Is Toxoplasma gondii type related to clinical outcome in human congenital infection? Systematic and critical review. Eur J Clin Microbiol Infect Dis. (2016) 35:1079–88. doi: 10.1007/s10096-016-2656-2

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Biddau M, Bouchut A, Major J, Saveria T, Tottey J, Oka O, et al. Two essential thioredoxins mediate apicoplast biogenesis, protein import, and gene expression in Toxoplasma gondii. PLoS Pathog. (2018) 14:e1006836. doi: 10.1371/journal.ppat.1006836

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Bosch SS, Kronenberger T, Meissner KA, Zimbres FM, Stegehake D, Stegehake NM, et al. Oxidative stress control by apicomplexan parasites. Biomed Res Int. (2015) 2015:351289. doi: 10.1155/2015/351289

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Hofmann B, Hecht HJ, Flohé L. Peroxiredoxins. Biol Chem. (2002) 383:347–64. doi: 10.1515/BC.2002.040

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Jones DP, Go YM. Redox compartmentalization and cellular stress. Diabetes Obes Metab. (2010) 12(Suppl 2):116–25. doi: 10.1111/j.1463-1326.2010.01266.x

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Luo M, Jiang YL, Ma XX, Tang YJ, He YX, Yu J, et al. Structural and biochemical characterization of yeast monothiol glutaredoxin Grx6. J Mol Biol. (2010) 398:614–22. doi: 10.1016/j.jmb.2010.03.029

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Cooper AJ, Pinto JT, Callery PS. Reversible and irreversible protein glutathionylation: biological and clinical aspects. Expert Opin Drug Metab Toxicol. (2011) 7:1183. doi: 10.1517/17425255.2011.577738

PubMed Abstract | CrossRef Full Text

14. Johansson C, Lillig CH, Holmgren A. Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J Biol Chem. (2004) 279:7537–43. doi: 10.1074/jbc.M312719200

CrossRef Full Text | Google Scholar

15. Shelton MD, Chock PB, Mieyal JJ. Glutaredoxin: role in reversible protein s-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxid Redox Signal. (2005) 7:348–66. doi: 10.1089/ars.2005.7.348

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Arnér ES, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. (2000) 267:6102–09. doi: 10.1046/j.1432-1327.2000.01701.x

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Powis G, Montfort WR. Properties and biological activities of thioredoxins. Annu Rev Pharmacol Toxicol. (2000) 41:261–95. doi: 10.1146/annurev.pharmtox.41.1.261

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Collet JF, Messens J. Structure, function, and mechanism of thioredoxin proteins. Antioxid Redox Signal. (2010) 13:1205–16. doi: 10.1089/ars.2010.3114

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Wang JL, Huang SY, Li TT, Chen K, Ning HR, Zhu XQ. Evaluation of the basic functions of six calcium-dependent protein kinases in Toxoplasma gondii using CRISPR-Cas9 system. Parasitol Res. (2016) 115:697–702. doi: 10.1007/s00436-015-4791-6

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Bai MJ, Wang JL, Elsheikha HM, Liang QL, Chen K, Nie LB, et al. Functional characterization of dense granule proteins in Toxoplasma gondii RH strain using CRISPR-Cas9 system. Front Cell Infect Microbiol. (2018) 8:300. doi: 10.3389/fcimb.2018.00300

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Cao XZ, Wang JL, Elsheikha HM, Li TT, Sun LX, Liang QL, et al. Characterization of the role of amylo-alpha-1,6-glucosidase protein in the infectivity of Toxoplasma gondii. Front Cell Infect Microbiol. (2019) 9:418. doi: 10.3389/fcimb.2019.00418

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Wang JL, Bai MJ, Elsheikha HM, Liang QL, Li TT, Cao XZ, et al. Novel roles of dense granule protein 12 (GRA12) in Toxoplasma gondii infection. FASEB J. (2020) 34:3165–78. doi: 10.1096/fj.201901416RR

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Joetzik E, Becker K. Thioredoxin and glutathione systems in Plasmodium falciparum. Int J Med Microbiol. (2012) 302:187–94. doi: 10.1016/j.ijmm.2012.07.007

CrossRef Full Text | Google Scholar

24. Kehr S, Sturm N, Rahlfs S, Przyborski JM, Becker K. Compartmentation of redox metabolism in malaria parasites. PLos Pathog. (2010) 6:e1001242. doi: 10.1371/journal.ppat.1001242

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Sharma A, Sharma A, Dixit S, Sharma A. A structural insights into thioredoxin-2: a component of malaria parasite protein secretion machinery. Sci Rep. (2011) 1:179. doi: 10.1038/srep00179

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Ding M, Clayton C, Soldati D. Toxoplasma gondii catalase: are there peroxisomes in toxoplasma? J Cell Sci. (2000) 113:2409–19.

PubMed Abstract | Google Scholar

27. Ding M, Kwok LY, Schlüter D, Clayton C, Soldati D. The antioxidant systems in Toxoplasma gondii and the role of cytosolic catalase in defence against oxidative injury. Mol Microbiol. (2004) 51:47–61. doi: 10.1046/j.1365-2958.2003.03823.x

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Akerman SE, Müller S. Peroxiredoxin-linked detoxification of hydroperoxides in Toxoplasma gondii. J Biol Chem. (2005) 280:564–70. doi: 10.1074/jbc.M406367200

PubMed Abstract | CrossRef Full Text | Google Scholar

29. DeRocher AE, Coppens I, Karnataki A, Gilbert LA, Rome ME, Feagin JE, et al. A thioredoxin family protein of the apicoplast periphery identifies abundant candidate transport vesicles in Toxoplasma gondii. Eukaryot Cell. (2008) 7:1518–29. doi: 10.1128/EC.00081-08

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Sheiner L, Demerly JL, Poulsen N, Beatty WL, Lucas O, Behnke MS, et al. A systematic screen to discover and analyze apicoplast proteins identifies a conserved and essential protein import factor. PLoS Pathog. (2011) 7:e1002392. doi: 10.1371/journal.ppat.1002392

PubMed Abstract | CrossRef Full Text | Google Scholar